cabazitaxel teva
teva b.v. - cabazitaxel - prostatic neoplasms - antineoplastic agents - treatment of prostate cancer
cabazitaxel teva 10 mg/ml inf. sol. (conc.) i.v. vial
teva b.v. - cabazitaxel 2-propanol solvate 64,3 mg - eq. cabazitaxel 60 mg - concentrate for solution for infusion - cabazitaxel
jevtana
sanofi israel ltd - cabazitaxel - concentrate and solvent for solution for infusion - cabazitaxel 60 mg / 1.5 ml - cabazitaxel - cabazitaxel - jevtana is indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel- containing treatment regimen.
cabazitaxel spc 60mg/1.5ml concentrate and solvent for solution for infusion
sudair pharma company, saudi arabia - cabazitaxel - concentrate and solvent for solution for infusion - 60 mg
cabazitaxel fresenius kabi 20 mg/ml inf. sol. (conc.) i.v. vial
fresenius kabi sa-nv - cabazitaxel 20 mg/ml - concentrate for solution for infusion - cabazitaxel
cabazitaxel mylan
mylan laboratories limited [otl] - cabazitaxel - solution; injection - 60mg/1.5ml
cabazitaxel ever pharma 10 mg/ml concentrate for solution for infusion 10mg mg/1 ml
مستودع ادوية الصباغ - sabbagh drug store - cabazitaxel solvent free 10mg mg/1 ml - 10mg mg/1 ml
cabazitaxel eg 20 mg/ml inf. sol. (conc.) i.v. vial
eg sa-nv - cabazitaxel 20 mg/ml - concentrate for solution for infusion - cabazitaxel
jevtana 60 mg
شركة ألفه للأدوية - ulfa pharma co. - cabazitaxel acetone solvate 60 mg, cabazitaxel solvent free 60 mg/1.5ml - 60 mg
jevtana® concentrate and solvent for solution for infusion 60mg1.5ml
sanofi-aventis singapore pte. ltd. - cabazitaxel - infusion, solution concentrate - 60mg/1.5ml - cabazitaxel 60mg/1.5ml